Abstract: An apparatus may include a memory and graphics logic operative to render a set of one or more data frames for storage in the memory using a received set of data of a digital medium, and output one or more control signals at a first interval. The apparatus may also include a display engine operative to receive the one or more control signals from the graphics logic, retrieve the set of one or more data frames from the memory, and send the one or more data frames to a display device for visual presentation. The one or more data frames may be sent periodically in succession at a second interval corresponding to a native frame rate of the digital medium.

Abstract: Methods and compositions for identification of candidate antigen-specific variable regions as well as generation of antibodies or antigen-binding fragments that could have desired antigen specificity are provided. For example, in certain aspects methods for determining amino acid sequences of serum antibody CDR and abundancy level are described. In some aspects, methods for determining nucleic acid sequences of antibody variable region sequences and frequency are provided. Furthermore, the invention provides methods for identification and generation of antibody or antigen-binding fragments that comprise highly-represented CDR.

Abstract: Biological source oils, including, but not limited to, algae oil, stabilize the presence of asphaltenes in petroleum feedstocks, such as crude oil, to help avoid or prevent problematic issues caused by the asphaltenes, such as sludges, plugging, deposits, fouling and/or corrosion in the production, transferring and processing of the petroleum feedstocks. Chemical additives such as phenol-based resins, and reaction products or combinations of long chain alpha-olefins and/or small chain aldehydes and/or long chain alkyl phenate sulfides and/or metal oxide-based colloidal hydrocarbon-based nanodispersions, may also stabilize the presence of asphaltenes in petroleum feedstocks. By “stabilizing” is meant keeping the asphaltenes in solution in the petroleum feedstocks.

Abstract: Industrial fluids may be monitored at the site of each industrial fluid by introducing a sample of the industrial fluid into a device employing a detection technique for detecting at least one composition within the sample. The detection technique may be or include surface enhanced Raman scattering (SERS), mass spectrometry (MS), nuclear magnetic resonance (NMR), ultraviolet light (UV) spectroscopy, UV spectrophotometry, indirect UV spectroscopy, contactless conductivity, laser induced fluorescence, and combinations thereof. In one non-limiting embodiment, a separation technique may be applied to the sample prior to the introduction of the sample into the device for detecting the composition.

Abstract: Industrial fluids may be monitored at the site of each industrial fluid by introducing a sample of the industrial fluid into a device employing a detection technique for detecting at least one composition within the sample. The detection technique may be or include surface enhanced Raman scattering (SERS), mass spectrometry (MS), nuclear magnetic resonance (NMR), ultraviolet light (UV) spectroscopy, UV spectrophotometry, indirect UV spectroscopy, contactless conductivity, laser induced fluorescence, and combinations thereof. In one non-limiting embodiment, a separation technique may be applied to the sample prior to the introduction of the sample into the device for detecting the composition.

Abstract: Methods and compositions involving polypeptides having an aglycosylated antibody Fc domain. In certain embodiments, polypeptides have an aglycosylated Fc domain that contains one or more substitutions compared to a native Fc domain. Additionally, some embodiments involve an Fc domain that is binds some Fc receptors but not others. For example, polypeptides are provided with an aglycosylated Fc domain that selectively binds Fc?RI at a level within 2-fold of a glycosylated Fc domain, but that is significantly reduced for binding to other Fc receptors. Furthermore, methods and compositions are provided for promoting antibody-dependent cell-mediated toxicity (ADCC) using a polypeptide having a modified aglycosylated Fc domain and a second non-Fc binding domain, which can be an antigen binding region of an antibody or a non-antigen binding region. Some embodiments concern antibodies with such polypeptides, which may have the same or different non-Fc binding domain.

Abstract: Methods and compositions involving polypeptides having an aglycosylated antibody Fc domain. In certain embodiments, polypeptides have an aglycosylated Fc domain that contains one or more substitutions compared to a native Fc domain. Additionally, some embodiments involve an Fc domain that is binds some Fc receptors but not others. For example, polypeptides are provided with an aglycosylated Fe domain that selectively binds Fc?RI at a level within 2-fold of a glycosylated Fc domain, but that is significantly reduced for binding to other Fc receptors. Furthermore, methods and compositions are provided for promoting antibody-dependent cell-mediated toxicity (ADCC) using a polypeptide having a modified aglycosylated Fc domain and a second non-Fc binding domain, which can be an antigen binding region of an antibody or a non-antigen binding region. Some embodiments concern antibodies with such polypeptides, which may have the same or different non-Fc binding domain.

Abstract: An apparatus may include a memory and graphics logic operative to render a set of one or more data frames for storage in the memory using a received set of data of a digital medium, and output one or more control signals at a first interval. The apparatus may also include a display engine operative to receive the one or more control signals from the graphics logic, retrieve the set of one or more data frames from the memory, and send the one or more data frames to a display device for visual presentation. The one or more data frames may be sent periodically in succession at a second interval corresponding to a native frame rate of the digital medium.

Abstract: A process for refining crude oil can be controlled to mitigate fouling by deploying a refractive index probe at a location suitable for making a crude oil stability determination, wherein the crude oil stability determination is relevant to controlling the refining process; making a measurement of crude oil stability; and then controlling the process for refining crude oil by maintaining the process or implementing a change to the process, based upon the determination of crude oil stability. This concept can also be applied to transporting, blending, and storing crude oil.

Abstract: Industrial fluids can be monitored by employing differential ion mobility spectrometer to sample the industrial fluids. This process may also include controlling an industrial device or an industrial process using the results of the output from the field asymmetric ion mobility spectrometer. The process may also include employing a device to condition the sample prior to introducing the sample into field asymmetric ion mobility spectrometer.

Abstract: Methods and compositions for identification of candidate antigen-specific variable regions as well as generation of antibodies or antigen-binding fragments that could have desired antigen specificity are provided. For example, in certain aspects methods for determining amino acid sequences of serum antibody CDR and abundancy level are described. In some aspects, methods for determining nucleic acid sequences of antibody variable region sequences and frequency are provided. Furthermore, the invention provides methods for identification and generation of antibody or antigen-binding fragments that comprise highly-represented CDR.

Abstract: Methods and compositions involving polypeptides having an aglycosylated antibody Fc domain. In certain embodiments, polypeptides have an aglycosylated Fc domain that contains one or more substitutions compared to a native Fc domain. Additionally, some embodiments involve an Fc domain that is binds some Fc receptors but not others. For example, polypeptides are provided with an aglycosylated Fe domain that selectively binds Fc?RI at a level within 2-fold of a glycosylated Fc domain, but that is significantly reduced for binding to other Fc receptors. Furthermore, methods and compositions are provided for promoting antibody-dependent cell-mediated toxicity (ADCC) using a polypeptide having a modified aglycosylated Fc domain and a second non-Fc binding domain, which can be an antigen binding region of an antibody or a non-antigen binding region. Some embodiments concern antibodies with such polypeptides, which may have the same or different non-Fc binding domain.

Abstract: Nanoparticles that activate complement in the absence of biological molecules are described. The nanoparticles are shown to specifically target antigen presenting cells in specifically in lymph nodes, without the use of a biological molecule for targeting. These particles are useful vehicles for delivering immunotherapeutics.